C. Chouaïd

18.3k citations
505 papers · 7.5k · 2 hit papers · h-index 42

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Pulmonary Hypertension Research and Treatments
  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Treatments and Mutations 172
    • Lung Cancer Diagnosis and Treatment 63
    • Chronic Obstructive Pulmonary Disease (COPD) Research 28
    • Cancer Immunotherapy and Biomarkers 67
    • Lung Cancer Research Studies 48
    • Colorectal Cancer Treatments and Studies 30

C. Chouaïd

462 papers receiving 7.3k citations

C. Chouaïd's Hit Papers

Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018 2020 · 223 citations
2230+4+8Years since publication100200300400500

Peers

C. Chouaïd
Comparison fields: 5 of 142
  • Pulmonary and Respiratory Medicine 3.7k
  • Oncology 2.6k
  • Cancer Research 520
  • Applied Microbiology and Biotechnology 61
  • Geriatrics and Gerontology 85
Replace Anil Kapoor with:
Anil Kapoor Canada
Maximilian Burger Germany
Marianne Paesmans Belgium
Stephen D. Cassivi United States
Ciro Gallo Italy
Mark F. Munsell United States
Elisa Rossi Italy
Paolo Bossi Italy
Ateeq Ur Rehman Ghafoor Pakistan
David P. Wood United States
C. Chouaïd relative to Anil Kapoor Canada Anil Kapoor's profile →
Citations per field
00.5×3.2×
Anil Kapoor · 1×
Citations per year

Countries citing papers authored by C. Chouaïd

Since Specialization
Citations

This map shows the geographic impact of C. Chouaïd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Chouaïd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Chouaïd more than expected).

Fields of papers citing papers by C. Chouaïd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Chouaïd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Chouaïd. The network helps show where C. Chouaïd may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Chouaïd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Chouaïd Line = papers co-authored together C. Chouaïd links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 505 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
Hit paper breakdown →
2013507
2 2009250
3
Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018
Hit paper breakdown →
2020223
4 2012170
5 2018141
6 2014137
7 2014132
8 2009131
9 2011121
10 2013121
11 2013119
12 2008104
13 1995102
14 2011100
15 201394
16 201989
17 201788
18 200087
19 201185
20 202276

About C. Chouaïd

C. Chouaïd is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Economics and Econometrics and Surgery, having authored 505 papers that have together received 7.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (172 papers), Cancer Immunotherapy and Biomarkers (67 papers), Lung Cancer Diagnosis and Treatment (63 papers), Lung Cancer Research Studies (48 papers), Economic and Financial Impacts of Cancer (32 papers), Colorectal Cancer Treatments and Studies (30 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (28 papers) and Health Systems, Economic Evaluations, Quality of Life (23 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.7k citations), Oncology (2.6k citations), Cancer Research (520 citations), Applied Microbiology and Biotechnology (61 citations) and Geriatrics and Gerontology (85 citations). C. Chouaïd has collaborated with scholars based in France, United States and Germany. Frequent co-authors include A. Vergnenègre, I. Monnet, Olivier Bylicki, Gilles Hejblum, Fabrice Barlési, Marie Wislez, Jean‐Baptiste Assié, Serge Adnot, Florian Guisier and Bernard Maître. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Value in Health, Annals of Oncology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact